Clinical Trials on Patients With Advanced Solid Tumors in United States
Total 3707 results
-
IconOVir BioRecruitingPatients With Advanced Solid TumorsUnited States
-
Elevar TherapeuticsBukwang Pharmaceutical, Co., Ltd.CompletedCancer Patients With Solid TumorsKorea, Republic of, United States
-
Memorial Sloan Kettering Cancer CenterCompletedPediatric Patients With Solid TumorsUnited States
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Nektar TherapeuticsCompletedAdvanced or Metastatic Solid Tumors in Patients With Hepatic ImpairmentUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
D3 Bio (Wuxi) Co., LtdRecruitingAdvanced Solid Tumors With MAPK Pathway MutationsAustralia, China, United States
-
Deciphera Pharmaceuticals LLCTerminatedMetastatic Solid Tumors | Locally Advanced Tumors | Cancers With MET Genomic Alterations | Cancers With TRK Genomic AlterationsUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Esperance Pharmaceuticals IncCompletedAdvanced Solid Tumors | Solid TumorsUnited States
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is AvailableUnited States
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.CompletedAdvanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Ascentage Pharma Group Inc.CompletedPatients With Advanced Solid Tumor or LymphomaUnited States
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
Hoffmann-La RocheCompletedSolid Tumors, Advanced Solid TumorsUnited States
-
Frontier Medicines CorporationRecruitingColorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Unresectable Solid Tumor | KRAS G12C | Advanced Solid Tumors With KRAS G12C MutationsUnited States
-
NeuPharma, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Genelux CorporationTemporarily not availableAdvanced Stage Cancer (Solid Tumor Disease for 4 Patients) | Acute Myeloid Leukemia (6 Patients)United States
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
Vividion Therapeutics, Inc.RecruitingAdvanced Solid Tumors | Advanced Hematologic TumorsUnited States, Australia
-
AbbottCompletedAdvanced Solid TumorsUnited States
-
SanofiCompletedAdvanced Solid TumorsUnited States
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Onconova Therapeutics, Inc.CompletedAdvanced Solid TumorsUnited States
-
Array Biopharma, now a wholly owned subsidiary...Completed
-
Georgetown UniversityWyeth is now a wholly owned subsidiary of PfizerCompletedAdvanced Solid TumorsUnited States
-
TyrogenexCompleted
-
Cyclacel Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced Solid TumorsUnited States
-
Jubilant Innovation Ltd.CompletedAdvanced Solid TumorsUnited States
-
AbbottTerminatedAdvanced Solid TumorsUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedCancer | Advanced Solid Tumors | TumorsUnited States
-
CanBas Co. Ltd.Completed
-
Purinomia Biotech, Inc.RecruitingAdvanced Solid TumorsUnited States
-
M.D. Anderson Cancer CenterGlaxoSmithKline; National Comprehensive Cancer NetworkCompletedSolid Tumors | Advanced CancersUnited States
-
Ionis Pharmaceuticals, Inc.M.D. Anderson Cancer CenterCompletedAdvanced Solid TumorsUnited States
-
OnKure, Inc.University of Colorado, DenverCompleted
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States
-
Dana-Farber Cancer InstituteCompletedAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
CStone PharmaceuticalsCompleted
-
ImmunityBio, Inc.Completed
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Canada, United Kingdom